Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

242
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
242
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

375
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
375
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

429
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
429
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

256
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
256
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

197
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
197

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients.

Journal of visualized experiments : JoVE·2026
Same author

Immunoglobulin G4-related coronary artery pseudo aneurysm presenting as non-ST-segment elevation myocardial infarction (NSTEMI): a rare case and surgical management.

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Hydatid cysts in the pulmonary artery: A rare cause of pulmonary embolism.

The National medical journal of India·2026
Same author

Alopecia following single-dose postoperative intravesical gemcitabine in nonmuscle-invasive bladder cancer: A multi-institutional case series.

Urologic oncology·2026
Same author

Impact of neighborhood deprivation on bladder cancer outcomes: A regional analysis.

Bladder cancer (Amsterdam, Netherlands)·2025
Same author

Management of clinical stage T3/T4 bladder cancer: a review.

World journal of urology·2025

相关实验视频

Updated: Jan 8, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.7K

在过导管大动脉置换后进行重新干预.

Vidur Bansal1, Ruchit Patel1, Pratyaksha Rana2

  • 1From the Department of Cardiothoracic and Vascular Surgery, U.N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.

Cardiology in review
|December 22, 2025
PubMed
概括

过导管大动脉置换 (TAVR) 后的重新干预变得越来越常见. 最佳的管理策略,包括重复TAVR或手术替代,对于患者的长期结果至关重要.

关键词:
心脏的门是心脏的门.重复重复 重复 重复 重复 重复 重复替代品 替代品 替代品 替代品手术 手术 手术 手术 手术 手术 手术通过透气管导入器.

更多相关视频

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

474
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.6K

相关实验视频

Last Updated: Jan 8, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.7K
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

474
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.6K

科学领域:

  • 心血管医学 心血管医学
  • 干预心脏病学 干预心脏病学
  • 生物材料科学 生物材料科学

背景情况:

  • 自2002年以来,过导管大动脉置换 (TAVR) 已经彻底改变了大动脉狭窄的治疗方法.
  • 越来越多的TAVR使用,特别是在年轻的患者中,预测由于膜退化,重新干预需求的增加.
  • 结构的恶化是TAVR的不可避免的长期并发症.

研究的目的:

  • 评估TAVR后需要重新干预的患者的最佳管理策略.
  • 评估TAVR初始管理选择对后续重新干预的长期影响.
  • 分析TAVR程序和设备故障的治疗选择.

主要方法:

  • 对TAVR后接受再干预的患者的临床数据和结果的审查.
  • 对不同的再干预方法的分析:第二次TAVR,通过大动脉置换的外科扩展剂和混合技术.
  • 检查了初始TAVR和随后的重新干预的患者选择标准.

主要成果:

  • 在不断增长的患者队列中,TAVR后的重新干预是不可避免的.
  • 对于TAVR衰竭的治疗选择包括重复TAVR,外科AVR或混合程序.
  • 初始管理的选择对长期结果和重新干预的必要性产生重大影响.

结论:

  • 仔细选择患者进行初始TAVR至关重要,以尽量减少未来的重新干预需求.
  • 存在一系列的重新干预选择,根据TAVR故障的具体原因进行调整.
  • 鉴于TAVR的患病率日益增加,制定最佳的再干预方案至关重要.